Influence of drugs of abuse and alcohol upon patients admitted to acute psychiatric wards: Physician's assessment compared to blood drug concentrations

Journal of Clinical Psychopharmacology

Volumn 33, Issue 3, 2013, Pages 415-419

  Mordal, Jon ^a,b   Medhus, Sigrid ^a,b   Holm, Bjørn ^a   Mørland, Jørg ^b,c   Bramness, Jørgen G ^b  

^a LOVISENBERG DIAKONALE HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

acute psychiatric admission; blood drug analyses; chromatographic methods; drug influence

Indexed keywords

ALCOHOL; AMPHETAMINE; CANNABIS; CLONAZEPAM; COCAINE; CODEINE; DIAZEPAM; FLUNITRAZEPAM; METHADONE; MORPHINE; NITRAZEPAM; OXAZEPAM; ZOPICLONE;

ADULT; ALCOHOL ABUSE; ARTICLE; CLINICAL ASSESSMENT; CROSS-SECTIONAL STUDY; DRUG ABUSE; DRUG BLOOD LEVEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHIATRIC DEPARTMENT;

ADULT; AGE FACTORS; ALCOHOL-RELATED DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT ADMISSION; PSYCHIATRIC DEPARTMENT, HOSPITAL; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SEX FACTORS; SUBSTANCE ABUSE DETECTION; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84877586047     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31828ec934     Document Type: Article

References (22)

1. Bonsack C, Camus D, Kaufmann N, et al. Prevalence of substance use in a Swiss psychiatric hospital: interview reports and urine screening. Addict Behav. 2006; 31: 1252-1258.
2. Flovig JC, Vaaler AE, Morken G. Substance use at admission to an acute psychiatric department. Nord J Psychiatry. 2009; 63: 113-119.
3. Schiller MJ, Shumway M, Batki SL. Patterns of substance use among patients in an urban psychiatric emergency service. Psychiatr Serv. 2000; 51: 113-115.
4. Schuckit MA. Comorbidity between substance use disorders and psychiatric conditions. Addiction. 2006; 101: 76-88.
5. Reeves RR, Pendarvis EJ, Kimble R. Unrecognized medical emergencies admitted to psychiatric units. Am J Emerg Med. 2000; 18: 390-393.
6. Ingum J, Bjorklund R, Bjorneboe A, et al. Relationship between drug plasma concentrations and psychomotor performance after single doses of ethanol and benzodiazepines. Psychopharmacology (Berl). 1992; 107: 11-17.
7. Kurzthaler I, Hummer M, Miller C et al. Effect of cannabis use on cognitive functions and driving ability. J Clin Psychiatry. 1999; 60: 395-399.
8. Bramness JG, Skurtveit S, Morland J. Testing for benzodiazepine inebriationVrelationship between benzodiazepine concentration and simple clinical tests for impairment in a sample of drugged drivers. Eur J Clin Pharmacol. 2003; 59: 593-601.
9. Bachs L, Skurtveit S, Morland J. Codeine and clinical impairment in samples in which morphine is not detected. Eur J Clin Pharmacol. 2003; 58: 785-789.
10. Bramness JG, Skurtveit S, Morland J. Clinical impairment of benzodiazepinesVrelation between benzodiazepine concentrations and impairment in apprehended drivers. Drug Alcohol Depend. 2002; 68: 131-141.
11. Gustavsen I, Morland J, Bramness JG. Impairment related to blood amphetamine and/or methamphetamine concentrations in suspected drugged drivers. Accid Anal Prev. 2006; 38: 490-495.
12. Khiabani HZ, Bramness JG, Bjorneboe A, et al. Relationship between THC concentration in blood and impairment in apprehended drivers. Traffic Inj Prev. 2006; 7: 111-116.
13. Bramness JG, Khiabani HZ, Morland J. Impairment due to cannabis and ethanol: clinical signs and additive effects. Addiction. 2010; 105: 1080-1087.
14. Sewell RA, Poling J, Sofuoglu M. The effect of cannabis compared with alcohol on driving. Am J Addict. 2009; 18: 185-193.
15. Nitschke K, Bennedsen BE, Kassow P, et al. [Incidence of alcohol abuse among patients with emergency admissions to a psychiatric department. Evaluation based on clinical and biochemical markers]. In Danish. Ugeskr Laeger. 1995; 157: 4567-4572.
16. Ruud T, Gra?we R, Hatling T. [Acute psychiatric treatment in NorwayVresults from a multicenter study, SINTEF Norway, 2006]. Report in Norwegian. Available at: www.sintef.no/upload/Helse/Psykisk%20helse/Pdf-filer/ MAPWeb.pdf. Accessed October 19, 2010.
17. Batki SL, Harris DS. Quantitative drug levels in stimulant psychosis: relationship to symptom severity, catecholamines and hyperkinesia. Am J Addict. 2004; 13: 461-470.
18. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987; 13: 261-276.
19. Mordal J, Holm B, Morland J, et al. Recent substance intake among patients admitted to acute psychiatric wards: physician's assessment and on-site urine testing compared with comprehensive laboratory analyses. J Clin Psychopharmacol. 2010; 30: 455-459.
20. Mordal J, Bramness JG, Holm B, et al. Drugs of abuse among acute psychiatric and medical admissions: laboratory based identification of prevalence and drug influence. Gen Hosp Psychiatry. 2008; 30: 55-60.
21. Darke S, Kaye S, McKetin R, et al. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev. 2008; 27: 253-262.
22. Gray SD, Fatovich DM, McCoubrie DL, et al. Amphetamine-related presentations to an inner-city tertiary emergency department: a prospective evaluation. Med J Aust. 2007; 186: 336-339.